Joshua Rutland, MD
Clinical Cardiac Electrophysiology · Tyler, TXNPI 1518225762
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (50.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medtronic at 45.8% of the total. Among clinical cardiac electrophysiology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 430 payments — averaging $389.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$77K
- Boston Scientific$54K
- Abbott$30K
- Medical Device Business Services, Inc.$2K
- Biosense Webster, Inc.$2K
- Cardiva Medical, Inc.$514
- plus $2K from 11 others
What the payments were for
- Consulting fees$12,1317%
- Speaking & faculty fees$49,61330%
- Grants$85,00051%
- Travel & lodging$6,1654%
- Food & beverage$14,0198%
- Education$5920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 106 | $76,725 |
| Boston Scientific | 96 | $54,404 |
| Abbott | 114 | $30,146 |
| Medical Device Business Services, Inc. | 3 | $2,480 |
| Biosense Webster, Inc. | 28 | $1,688 |
| Cardiva Medical, Inc. | 22 | $514 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $319 |
| EKOS Corporation | 2 | $265 |
| Pfizer | 14 | $236 |
| EBR Systems, Inc. | 1 | $153 |
| Sanofi-aventis U.S. LLC | 10 | $147 |
| Johnson & Johnson | 2 | $111 |
| E.r. Squibb & Sons, L.L.C. | 6 | $106 |
| Altathera Pharmaceuticals LLC | 2 | $68 |
| Inspire Medical Systems, Inc. | 3 | $67 |
| Philips North America LLC | 2 | $50 |
| Irhythm Technologies, Inc. | 2 | $41 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL EP$41,563
- AVEIR$11,530
- Carto 3$3,375
- Farapulse$2,760
- EVERA MRI XT DR SURESCAN$891
- Micra$760
- GENERAL BRADY$750
- EMBLEM MRI S-ICD$300
- EKOSONIC$265
- WATCHMAN Access System$232
- Cobalt$222
- AFFERA MAPPING SYSTEM$221
- GENERAL - THERAPIES$157
- ENSITE$140
- Ensite Cardiac Mapping System$137
- Accent Pacemaker$129
- SQ RX PULSE GENERATOR$115
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$114
- Capsure$114
- Cardiva VASCADE MVP VVCS 6-12F$110
How this compares
$167,520 in reported general payments places this provider in the 90th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 394 | $425,296 |
| MultaqDronedarone Hcl | 33 | $37,125 |
| XareltoRivaroxaban | 25 | $24,508 |
| Flecainide Acetate | 124 | $4,312 |
| Metoprolol Succinate | 149 | $3,627 |
| Amiodarone Hcl | 141 | $2,373 |
| Metoprolol Tartrate | 125 | $792 |
| SotalolSotalol Hcl | 26 | $725 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 15 | $487 |
| Digoxin | 15 | $219 |
| Carvedilol | 30 | $100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $236 | $425,296394 claims |
| Sanofi-aventis U.S. LLCMultaq | $147 | $37,12533 claims |
| Johnson & JohnsonXarelto | $111 | $24,50825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Tyler
- John SimsTyler$204K
- Michael DelaughterBedford$1.6M
- Andrea NataleAustin$1.3M
- Jason ZagrodzkyAustin$961K
- Amin Al-AhmadAustin$771K
- Dale YooMcKinney$585K
- Rodney HortonAustin$553K
- Jose Cuellar SilvaWebster$502K
- Miguel ValderrabanoHouston$461K
- Theodore TakataFort Worth$396K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.